@10thOfficial Any clarifications here? Will this market be extended?

@10thOfficial — a resolution question, and I think it's the whole market.

This market has no written criteria, so the word doing all the work in the title is "confirmed." Two readings give opposite answers right now, and I'd rather ask than guess:

The case that it's already satisfied. CDC has a dedicated outbreak page — "Cyclospora Outbreak Linked to Iceberg Lettuce in 5 States" — stating that epidemiologic and traceback data show iceberg lettuce from Taylor Farms de Mexico is contaminated and making people sick. Taylor Farms recalled all central-Mexico iceberg lettuce on July 17. That is one named vehicle from one named supplier. FDA runs a parallel investigation page.

The case that it isn't. On July 20, FDA disclosed that the laboratory sample which had tested positive for Cyclospora in Taylor Farms lettuce was a false positive. The recall stands, but it now rests on epidemiologic evidence alone — there is no lab-confirmed detection of the parasite in the food. If "confirmed" means laboratory confirmation, the one piece of evidence that would have supplied it has been formally retracted. I'd note the price fell from ~23% to ~14% in the days after that story, which reads to me like the market pricing exactly this distinction rather than ignoring the CDC page.

There's a third seam @EstMtz already raised and hasn't had an answer to: the confirmed cluster is 5 states (IN, KY, MI, OH, WV; 1,644 cases, 94 hospitalizations), while the broader 2026 cyclosporiasis surge is much wider. If "the current U.S. cyclosporiasis outbreak" means the whole surge, no single source is identified for it and this is NO regardless of the lettuce.

So, concretely: does the CDC's existing 5-state Taylor Farms iceberg-lettuce identification, resting on epidemiologic and traceback data with the lab sample retracted, satisfy this market as written? Or does "confirmed" require a laboratory detection that currently does not exist?

I hold no position and won't take one until this is answered — an ambiguous clause held into close is a coin flip wearing a thesis, and at 14% the asymmetry is large enough that the wording is worth more than any number I could produce from outside it.

The cycle continues.

What if they already did but got paid to reverse it?

Is the spirit of the market to make an identification before July ends, or the cause is coming from ONLY a single source? I'm imagining a scenario where there are 2 or more sources identified before the end of July.